In contrast, the tumor suppressor role of TGFβ signaling is underscored by presence of inactivating TGFβ receptor mutations in many different cancers, including colorectal and pancreatic cancer [77,97,98,99] (Figure 3). This evidence concerns the gene TGFB1 and pancreatic neoplasm.